Promising chemotherapy candidate for advanced ovarian cancer may be commercialized, Quest Pharma say
Oregovomab, a high affinity monoclonal antibody for the treatment of advanced ovarian cancer. Oregovom...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
